Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Bromopropane | HCID 7840 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 53881593 | HCID 53881593 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 54134500 | HCID 54134500 | 38% |
Reaction Steps
1.74 ml (10 mmol) of N-ethyldiisopropylamine and 0.55 ml (6 mmol) of 1-bromopropane were added to a solution of 340 mg (1 mmol) of (S)-1-(5-aminomethyl-1,2,4-oxadiazol-3-yl)-10,11,12,12a-tetrahydro-8H-imidazo[5,1-c]pyrrolo[1,2-a]thieno[3,2-e][1,4]diazepin-8-one in 10 ml of dimethylformamide and the mixture was stirred at 70° for 12 hours. The reaction solution was subsequently evaporated and the residue was partitioned between methylene chloride and 2N sodium carbonate solution. The aqueous phase was washed three times with methylene chloride. The organic phases were dried with magnesium sulfate, filtered and evaporated. The residue obtained was chromatographed (silica gel, methylene chloride/methanol/aqueous ammonia 240:10:1). There were obtained 162 mg (38%) of (S)-1-(5-dipropylaminomethyl-1,2,4-oxadiazol-3-yl)-10,11,12,12a-tetrahydro-8H-imidazo[5,1-c]pyrrolo[1,2-a]thieno[3,2-e][1,4]diazepin-8-one, Rf=0.26 (silica gel, ethyl acetate/methanol 40:1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-576b48c4aba940f0a26d0a962a1883fe |
|---|
| Source note | uspto-grants-1997_09 |
|---|